RecruitingNot ApplicableNCT07348224

Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine and Nicotine Analogues


Sponsor

Insel Gruppe AG, University Hospital Bern

Enrollment

24 participants

Start Date

Aug 5, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Electronic cigarettes are battery-operated devices that can produce an aerosol by heating a liquid which commonly contains nicotine. In recent years, products containing synthetically produced nicotine and nicotine analogues have entered the market. However, it remains unclear whether these types of nicotine have the same effects as conventional nicotine derived from the tobacco plant. The aim of this study is to investigate the effects of these nicotine types and to gain a better understanding of their respective mechanisms of action.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Vaping of 6-methylnicotine, Vaping of racemic nicotine (S-/R-nicotine), and others for people with nicotine, nicotine analogues, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERVaping of synthetic S-nicotine

Vaping of e-liquids containing synthetic S-nicotine

OTHERVaping of racemic nicotine (S-/R-nicotine)

Vaping of e-liquids containing synthetic racemic nicotine (S-/R-nicotine)

OTHERVaping of 6-methylnicotine

Vaping of e-liquids containing the nicotine analogue 6-methylnicotine (6MN)


Locations(1)

Inselspital

Bern, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07348224


Related Trials